Sangamo Biosciences reported $120.26M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Alnylam Pharmaceuticals ALNY:US $ 534.08M 285.89M
Amgen AMGN:US $ 6528M 1461M
Avrobio Inc AVRO:US $ 161.66M 27.9M
Bayer BAYN:GR € 5785M 1221M
Biocryst Pharmaceuticals BCRX:US $ 395.5M 108.88M
Biogen BIIB:US $ 1749.3M 512.1M
Biomarin Pharmaceutical BMRN:US $ 605.44M 18.16M
Bluebird Bio BLUE:US $ 106.26M 54.9M
Gilead Sciences GILD:US $ 4296M 1042M
GlaxoSmithKline GSK:LN 10967M 6693M
Intercept Pharmaceuticals ICPT:US $ 48.32M 36.39M
IONIS PHARMACEUT IONS:US $ 542.51M 326.68M
Johnson & Johnson JNJ:US $ 1579M 322M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Merk MRK:US $ 8556M 460M
Novartis NOVN:VX SF 13852M 1445M
Omeros OMER:US $ 8.96M 91.84M
Pfizer PFE:US $ 2470M 526M
Regulus Therapeutics RGLS:US $ 53.9M 6.48M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Sarepta Therapeutics SRPT:US $ 1233.88M 881.99M
Ultragenyx Pharmaceutical RARE:US $ 153.99M 153.6M
Vertex Pharmaceuticals VRTX:US $ 7600.1M 805.1M
Ziopharm Oncology ZIOP:US $ 68.26M 7.8M